Æȷοì
Francis Doyle
Francis Doyle
seas.harvard.eduÀÇ À̸ÞÀÏ È®ÀεÊ
Á¦¸ñ
Àοë
Àοë
¿¬µµ
Process dynamics and control
DE Seborg, TF Edgar, DA Mellichamp, FJ Doyle III
John Wiley & Sons, 2016
55592016
Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range
T Battelino, T Danne, RM Bergenstal, SA Amiel, R Beck, T Biester, E Bosi, ...
Diabetes care 42 (8), 1593-1603, 2019
28572019
International consensus on use of continuous glucose monitoring
T Danne, R Nimri, T Battelino, RM Bergenstal, KL Close, JH DeVries, ...
Diabetes care 40 (12), 1631-1640, 2017
18882017
Robustness of cellular functions
J Stelling, U Sauer, Z Szallasi, FJ Doyle, J Doyle
Cell 118 (6), 675-685, 2004
12632004
Dynamic flux balance analysis of diauxic growth in Escherichia coli
R Mahadevan, JS Edwards, FJ Doyle
Biophysical journal 83 (3), 1331-1340, 2002
10492002
Survey on iterative learning control, repetitive control, and run-to-run control
Y Wang, F Gao, FJ Doyle III
Journal of process control 19 (10), 1589-1600, 2009
8742009
A model-based algorithm for blood glucose control in type I diabetic patients
RS Parker, FJ Doyle, NA Peppas
IEEE Transactions on biomedical engineering 46 (2), 148-157, 1999
8051999
Intercellular coupling confers robustness against mutations in the SCN circadian clock network
AC Liu, DK Welsh, CH Ko, HG Tran, EE Zhang, AA Priest, ED Buhr, ...
Cell 129 (3), 605-616, 2007
8012007
Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes
SA Brown, BP Kovatchev, D Raghinaru, JW Lum, BA Buckingham, ...
New England Journal of Medicine 381 (18), 1707-1717, 2019
7952019
Method and apparatus for glucose control and insulin dosing for diabetics
FJ Doyle III, L Jovanovic
US Patent 7,651,845, 2010
5892010
Robust H¡Ä glucose control in diabetes using a physiological model
RS Parker, FJ Doyle III, JH Ward, NA Peppas
AIChE Journal 46 (12), 2537-2549, 2000
5692000
Identification and control using Volterra models
FJ Doyle, RK Pearson, BA Ogunnaike
Springer, 2002
5212002
Identification of small molecule activators of cryptochrome
T Hirota, JW Lee, PC St. John, M Sawa, K Iwaisako, T Noguchi, ...
Science 337 (6098), 1094-1097, 2012
4832012
Closed-loop artificial pancreas systems: engineering the algorithms
FJ Doyle III, LM Huyett, JB Lee, HC Zisser, E Dassau
Diabetes care 37 (5), 1191-1197, 2014
4452014
Nonlinear model-based control using second-order Volterra models
FJ Doyle III, BA Ogunnaike, RK Pearson
Automatica 31 (5), 697-714, 1995
3981995
Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia
M Breton, A Farret, D Bruttomesso, S Anderson, L Magni, S Patek, ...
Diabetes 61 (9), 2230-2237, 2012
3582012
Robustness properties of circadian clock architectures
J Stelling, ED Gilles, FJ Doyle III
Proceedings of the National Academy of Sciences 101 (36), 13210-13215, 2004
3222004
The intravenous route to blood glucose control
RS Parker, FJ Doyle, NA Peppas
IEEE Engineering in Medicine and Biology Magazine 20 (1), 65-73, 2001
3142001
A novel computational model of the circadian clock in Arabidopsis that incorporates PRR7 and PRR9
MN Zeilinger, EM Farré, SR Taylor, SA Kay, FJ Doyle III
Molecular Systems Biology 2 (1), 58, 2006
2842006
Glucose-sensitivity of glucose oxidase-containing cationic copolymer hydrogels having poly (ethylene glycol) grafts
K Podual, FJ Doyle III, NA Peppas
Journal of Controlled Release 67 (1), 9-17, 2000
2822000
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20